机构:[1]The Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041, China.四川大学华西医院[2]The Department of Medical Oncology, Sichuan Cancer Hospital No.55, Ren Min Nan Road Si Duan, Chengdu, Sichuan, 610041, China.四川省肿瘤医院[3]Oncology Department, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital No.32, First Ring Road Xi Er Duan, Chengdu, Sichuan, 610041, China.四川省人民医院[4]The Department of Gastrointestinal Surgery, West China Hospital, Sichuan University No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041, China.四川大学华西医院[5]The Department of Medical Oncology, Yunnan Cancer Hospital Ren Min Xi Road, Kunming, Yunnan, 650001, China.[6]The Department of Medical Oncology, Affiliated Hospital of Xinjiang Medical College No.1, Liyushan Road, Urumqi, Xiangjiang, 830054, China.[7]The Department of Radiation Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041, China.四川大学华西医院[8]West China School of Public Health, Sichuan University, No.17 Section 3, Renmin South Road, Chengdu, Sichuan, 610044, China.
Background: The National Comprehensive Cancer Network clinical practice guidelines in oncology-gastric cancer guidelines have been widely used to provide appropriate recommendations for the treatment of patients with gastric cancer. The aim of this study was to examine the adherence of surgical oncologists, medical oncologists, and radiation oncologists' to the recommended guidelines. Methods: A questionnaire asking the treatment options for gastric cancer cases was sent to 394 Chinese oncology specialists, including surgical oncologists, medical oncologists, and radiation oncologists working in hospitals joined in The Western Cooperative Gastrointestinal Oncology Group of China. The questionnaire involved a series of clinical scenarios regarding the interpretation of surgery, neoadjuvant, adjuvant, and advanced treatment planning of gastric cancer. Results: Analysis of 358 respondents (91%) showed variations between each specialization and from the recommended guidelines in the management approaches to specific clinical scenarios. The majority of specialists admitted that less than 50% of patients received multidisciplinary evaluation before treatment. The participants gave different responses to questions involving adjuvant, neoadjuvant, and advanced settings, compared to the recommended guidelines. Conclusions: These results highlight the heterogeneity of the treatment of gastric cancer. Surgical oncologists, medical oncologists, and radiation oncologists are not adhering to the recommended guidelines.
第一作者机构:[1]The Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University No. 37, Guo Xue Xiang, Chengdu, Sichuan, 610041, China.
通讯作者:
推荐引用方式(GB/T 7714):
Xiaolong Zhang,Nanjing Li,Wen Wei,et al.Clinical management of gastric cancer: results of a multicentre survey[J].BMC CANCER.2011,11:doi:10.1186/1471-2407-11-369.
APA:
Xiaolong Zhang,Nanjing Li,Wen Wei,Wenxiu Yao,Ke Xie...&Qiu Li.(2011).Clinical management of gastric cancer: results of a multicentre survey.BMC CANCER,11,
MLA:
Xiaolong Zhang,et al."Clinical management of gastric cancer: results of a multicentre survey".BMC CANCER 11.(2011)